Robert Kleszcz

Dr. Robert Kleszcz

Poznan Univeristy of Medical Sciences
orcid

Research Focus & Metrics

Academic Career Length

14Years (2013-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 May 2013 in Journal of Applied Genetics
Verified
Journal Article
Open access
PDF file
Aleksandra Majchrzak-CelińskaAleksandra Majchrzak-Celińska
Aleksandra Majchrzak-Celińska
JPJaroslaw Paluszczak
Jaroslaw Paluszczak
Robert KleszczRobert Kleszcz
Robert Kleszcz
MMMarta Magiera
Marta Magiera
Anna-Maria BarciszewskaAnna-Maria Barciszewska
Anna-Maria Barciszewska
Wanda Baer-DubowskaWanda Baer-Dubowska
Wanda Baer-Dubowska
Despite the growing understanding of the mechanisms of carcinogenesis, cancers of the central nervous system are usually associated with unfavorable prognosis. The use of an appropriate molecular marker may improve the treatment outcome by allowing early diagnosis and treatment susceptibility monitoring. Since methylation of tumor-derived DNA can be detected in the serum of cancer patients, this makes DNA methylation-based biomarkers one of the most promising diagnostic strategies. In this study, the methylation profiles of MGMT, RASSF1A, p15INK4B, and p14ARF genes were evaluated in serum free-circulating DNA and the corresponding tumor tissue in a group of 33 primary or metastatic central nervous system cancer patients. Gene promoter methylation was assessed using methylation-specific polymerase chain reaction (PCR). All the tested genes were found to be methylated to a different extent in both serum and tumor samples. In comparison to metastatic brain tumor patients, the patients with glial tumors were characterized by a higher frequency of gene hypermethylation. The hypermethylation of RASSF1A differentiated primary from metastatic brain cancers. Moreover, the gene methylation profiles observed in serum, in most cases, matched the methylation profiles detected in paired tumor samples.

8 September 2017 in Molecular and Cellular Biochemistry
Verified
Journal Article
Open access
PDF file
JPJaroslaw Paluszczak
Jaroslaw Paluszczak
Robert KleszczRobert Kleszcz
Robert Kleszcz
ESElżbieta Studzińska-Sroka
Elżbieta Studzińska-Sroka
Violetta Krajka-KuźniakVioletta Krajka-Kuźniak
Violetta Krajka-Kuźniak
Lichens are a source of secondary metabolites which possess important biological activities, including antioxidant, antibacterial, anti-inflammatory, and cytotoxic effects. The anticancer activity of lichens was shown in many types of tumors, including colorectal cancers (CRC). Several studies revealed that the application of lichen extracts diminished the proliferation of CRC cells and induced apoptosis. Colon carcinogenesis is associated with aberrations in Wnt signaling. Elevated transcriptional activity of β-catenin induces cell survival, proliferation, and migration. Thus, the inhibition of Wnt signaling is a promising therapeutic strategy in colorectal cancer. The aim of this study was the evaluation of the effects of lichen-derived depsides (atranorin, lecanoric acid, squamatic acid) and depsidones (physodic acid, salazinic acid) and a poly-carboxylic fatty acid—caperatic acid, on Wnt signaling in HCT116 and DLD-1 colorectal cancer cell lines. HCT116 cells were more sensitive to the modulatory effects of the compounds. PKF118-310, which was used as a reference β-catenin inhibitor, dose-dependently reduced the expression of the classical β-catenin target gene—Axin2 in both cell lines. Lecanoric acid slightly reduced Axin2 expression in HCT116 cells while caperatic acid tended to reduce Axin2 expression in both cell lines. Physodic acid much more potently decreased Axin2 expression in HCT116 cells than in DLD-1 cells. Physodic acid and caperatic acid also diminished the expression of survivin and MMP7 in a cell line and time-dependent manner. None of the compounds affected the nuclear translocation of β-catenin. This is the first report showing the ability of caperatic acid and physodic acid to modulate β-catenin-dependent transcription.

1 December 2015 in Pharmacological Reports
Verified
Journal Article
Closed access
Robert KleszczRobert Kleszcz
Robert Kleszcz
JPJaroslaw Paluszczak
Jaroslaw Paluszczak
Wanda Baer-DubowskaWanda Baer-Dubowska
Wanda Baer-Dubowska

3 May 2021 in BMC Cancer
Verified
Journal Article
Open access
PDF file
Aleksandra Majchrzak-CelińskaAleksandra Majchrzak-Celińska
Aleksandra Majchrzak-Celińska
Julia O. MisiorekJulia O. Misiorek
Julia O. Misiorek
NKNastassia Kruhlenia
Nastassia Kruhlenia
ŁPŁukasz Przybył
Łukasz Przybył
Robert KleszczRobert Kleszcz
Robert Kleszcz
Violetta Krajka-KuźniakVioletta Krajka-Kuźniak
Violetta Krajka-Kuźniak
Background: Glioblastoma (GBM) is the deadliest and the most common primary brain tumor in adults. The invasiveness and proliferation of GBM cells can be decreased through the inhibition of Wnt/β-catenin pathway. In this regard, celecoxib is a promising agent, but other COXIBs and 2,5-dimethylcelecoxib (2,5-DMC) await elucidation. Thus, the aim of this study was to analyze the impact of celecoxib, 2,5-DMC, etori-, rofe-, and valdecoxib on GBM cell viability and the activity of Wnt/β-catenin pathway. In addition, the combination of the compounds with temozolomide (TMZ) was also evaluated. Cell cycle distribution and apoptosis, MGMT methylation level, COX-2 and PGE2 EP4 protein levels were also determined in order to better understand the molecular mechanisms exerted by these compounds and to find out which of them can serve best in GBM therapy. Methods: Celecoxib, 2,5-DMC, etori-, rofe- and valdecoxib were evaluated using three commercially available and two patient-derived GBM cell lines. Cell viability was analyzed using MTT assay, whereas alterations in MGMT methylation level were determined using MS-HRM method. The impact of COXIBs, in the presence and absence of TMZ, on Wnt pathway was measured on the basis of the expression of β-catenin target genes. Cell cycle distribution and apoptosis analysis were performed using flow cytometry. COX-2 and PGE2 EP4 receptor expression were evaluated using Western blot analysis. Results: Wnt/β-catenin pathway was attenuated by COXIBs and 2,5-DMC irrespective of the COX-2 expression profile of the treated cells, their MGMT methylation status, or radio/chemoresistance. Celecoxib and 2,5-DMC were the most cytotoxic. Cell cycle distribution was altered, and apoptosis was induced after the treatment with celecoxib, 2,5-DMC, etori- and valdecoxib in T98G cell line. COXIBs and 2,5-DMC did not influence MGMT methylation status, but inhibited COX-2/PGE2/EP4 pathway. Conclusions: Not only celecoxib, but also 2,5-DMC, etori-, rofe- and valdecoxib should be further investigated as potential good anti-GBM therapeutics.

14 May 2019 in Cellular Oncology
Verified
Journal Article
Open access
PDF file
Robert KleszczRobert Kleszcz
Robert Kleszcz
ASAnna Szymańska
Anna Szymańska
Violetta Krajka-KuźniakVioletta Krajka-Kuźniak
Violetta Krajka-Kuźniak
WBWanda Baer-Dubowska
Wanda Baer-Dubowska
JPJaroslaw Paluszczak
Jaroslaw Paluszczak
Purpose Activation of the Wnt pathway contributes to the development of head and neck squamous cell carcinomas (HNSCC) and its inhibition has recently emerged as a promising therapeutic strategy. Here, we aimed at identifying suitable molecular targets for down-regulation of canonical Wnt signaling in HNSCC cells. Methods Candidate target genes (PORCN, WNT3A, FZD2, FZD5, LRP5, DVL1, CIP2A, SET, KDM1A, KDM4C, KDM6A, CBP, CARM1, KMT2A, TCF7, LEF1, PYGO1, XIAP) were silenced using siRNA and selected targets were subsequently blocked using small molecule inhibitors. The effect of this treatment on the expression of β-catenin-dependent genes was assessed by qRT-PCR. The effect of the inhibitors on cell viability was evaluated using a resazurin assay in HNSCC-derived cell lines. A luciferase reporter assay was used for confirmation of the inhibition of Wnt-dependent gene expression. Cell migration was evaluated using a scratch wound healing assay. Cytometric analysis of propidium iodide stained cells was used for cell cycle distribution evaluation, whereas cytometric analysis of caspase 3/7 activity was used for apoptosis induction evaluation. Results We found that inhibition of Porcupine and CBP/β-catenin interaction by IWP-2 and PRI-724, respectively, most strongly affected β-catenin-dependent gene expression in HNSCC cells. These inhibitors also induced apoptosis and affected HNSCC cell migration. Conclusions Targeting Porcupine or the CBP/β-catenin interaction seems to be an effective strategy for the inhibition of canonical Wnt signaling in HNSCC cells. Further studies are required to confirm the possible therapeutic effect of IWP-2 and PRI-724 in HNSCC.

1 June 2020 in Toxicology in Vitro
Verified
Journal Article
Closed access
Violetta Krajka-KuźniakVioletta Krajka-Kuźniak
Violetta Krajka-Kuźniak
MCMarta Cykowiak
Marta Cykowiak
HSHanna Szaefer
Hanna Szaefer
Robert KleszczRobert Kleszcz
Robert Kleszcz
WBWanda Baer-Dubowska
Wanda Baer-Dubowska